The Myrovlytis Trust is a charity founded in 2007 to transform the outlook for rare conditions. With an initial focus on Birt-Hogg-Dubé Syndrome and osteosarcoma, the trust strategically funds research directed towards new treatments. We want to ensure that patients gain access to the same state-of-the-art technologies, breakthroughs and therapies as those with more common disease.
Rare Genetic Disorders
We have a long standing interest in rare genetic kidney disorders, particularly Birt-Hogg-Dubé syndrome. We fund research, provide support to patient groups and raise awareness through the BHD Foundation.
We are interested in advancing research and identifying novel therapies in rare cancers. Our initial focus is on osteosarcoma, where there is an urgent clinical unmet need to improve prognosis.
Connect with us…
Back to top